Pots 24-2260. Custom order, SDM-8 tin precursor 200 MG per vial(R)-SDM-8 STANDARD10 MG per vial(S)-SDM-8 STANDARD5 MG per vial

Ended Purchase Order Awarded Last action

Contract number
75N95024P00191
Awardee
Awarding agency
Obligated
$11,210

Award facts

Contract value 100% obligated
$11,210.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325411 Medicinal and Botanical Manufacturing
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21224, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $11,210.00 Firm Fixed Price Purchase Order to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH, a foreign-owned for-profit limited liability company. The contract, which does not have a set-aside designation, is for the delivery of custom order quantities of the SDM-8 tin precursor compound in 200 mg, 10 mg, and 5 mg vials. The place of performance is Baltimore, Maryland, and the completion date is March 18, 2025.

Quick answers

Who was awarded contract 75N95024P00191?

75N95024P00191 was awarded to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH by National Institute on Drug Abuse (National Institutes of Health) on March 19, 2024.

How much is contract 75N95024P00191 worth?

The government has obligated $11,210 on 75N95024P00191.

Was contract 75N95024P00191 competed?

The extent of competition for 75N95024P00191 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award